Spruce Biosciences, Inc.
SPRB
$0.0649
-$0.001-1.52%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -71.27% | -51.32% | -1.40% | 131.82% | 415.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -71.27% | -51.32% | -1.40% | 131.82% | 415.63% |
| Cost of Revenue | -2.29% | -6.10% | -23.55% | 1.26% | 25.09% |
| Gross Profit | -16.14% | -5.50% | 27.54% | 12.81% | -4.04% |
| SG&A Expenses | 3.43% | 15.76% | 10.11% | 12.51% | 9.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.03% | -1.64% | -16.29% | 3.81% | 21.38% |
| Operating Income | -12.80% | -8.00% | 18.32% | 6.58% | -5.50% |
| Income Before Tax | -18.61% | -10.68% | 19.72% | 10.49% | 0.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.61% | -10.68% | 19.72% | 10.49% | 0.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.61% | -10.68% | 19.72% | 10.49% | 0.96% |
| EBIT | -12.80% | -8.00% | 18.32% | 6.58% | -5.50% |
| EBITDA | -12.87% | -8.05% | 18.30% | 6.55% | -5.52% |
| EPS Basic | -15.12% | -1.48% | 35.75% | 37.08% | 38.46% |
| Normalized Basic EPS | -15.12% | -1.48% | 35.74% | 37.07% | 38.45% |
| EPS Diluted | -15.12% | -1.48% | 35.75% | 37.08% | 38.46% |
| Normalized Diluted EPS | -15.12% | -1.48% | 35.74% | 37.07% | 38.45% |
| Average Basic Shares Outstanding | 2.92% | 7.22% | 20.21% | 36.95% | 59.14% |
| Average Diluted Shares Outstanding | 2.92% | 7.22% | 20.21% | 36.95% | 59.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |